On August 7, 2019, Aprogen pharmaceuticals,Inc. (KOSE:A003060) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,631 KRW | +5.84% | +5.16% | -43.76% |
1st Jan change | Capi. | |
---|---|---|
-43.76% | 74.21M | |
+32.78% | 695B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+16.91% | 239B | |
+8.09% | 204B | |
-8.02% | 198B | |
+8.52% | 168B |
- Stock Market
- Equities
- A003060 Stock
- News Aprogen Biologics Inc.
- Aprogen pharmaceuticals,Inc. announced that it has received KRW 20.000000214 billion in funding from Aprogen KIC Inc.